Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Motus Nova Foot Device for Patients With Hemiplegia

NCT: NCT07754773 · NOT_YET_RECRUITING

NCT IDNCT07754773
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2027-12
SponsorMultiCare Health System Research Institute (OTHER)
First posted
Last updated

Brief Summary

Individuals with hemiplegia commonly demonstrate gait deviations such as difficulties with heel strike at initial contact, foot drop in swing, asymmetrical limb loading, muscle activation, and balance impairments. This study evaluates whether a therapeutic device (Motus Nova Foot; FDA approved) used in the home setting can increase heel strike, decrease limp, improve foot clearance in swing phase, improve quality of active muscle contraction of the affected limb, and improve balance. The Motus Nova Foot moves the ankle/foot and uses guided computer/video activities to encourage active participation while automatically recording device use and duration.

Frequently Asked Questions

What is Motus Nova Foot Device for Patients With Hemiplegia?

Motus Nova Foot Device for Patients With Hemiplegia is a clinical trial registered under NCT07754773. Current status: NOT_YET_RECRUITING.

What is the status of NCT07754773?

The current status of NCT07754773 (Motus Nova Foot Device for Patients With Hemiplegia) is: NOT_YET_RECRUITING.

When did Motus Nova Foot Device for Patients With Hemiplegia start?

Motus Nova Foot Device for Patients With Hemiplegia started on 2026-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.